Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Database
Language
Publication year range
1.
Int J Pharm ; 591: 119985, 2020 Dec 15.
Article in English | MEDLINE | ID: mdl-33069891

ABSTRACT

Androgens play a central role in homeostatic and pathological processes of the prostate gland. At the cellular level, testosterone activates both the genomic signaling pathway, through the intracellular androgen receptor (AR), and membrane-initiated androgen signaling (MIAS), by plasma membrane receptors. We have previously shown that the activation of MIAS induces uncontrolled proliferation and fails to stimulate the beneficial immunomodulatory effects of testosterone in prostatic cells, becoming necessary to investigate if genomic signaling mediates homeostatic effects of testosterone. However, the lack of specific modulators for genomic androgen signaling has delayed the understanding of this mechanism. In this article, we demonstrate that monosialoganglioside (GM1) micelles are capable of delivering testosterone into the cytoplasm to specifically activate genomic signaling. Stimulation with testosterone-loaded GM1 micelles led to the activation of androgen response element (ARE)-regulated genes in vitro as well as to the recovery of normal prostate size and histology after castration in mice. In addition, these micelles avoided MIAS, as demonstrated by the absence of rapid signaling pathway activation and the inability to induce uncontrolled cell proliferation. In conclusion, our results validate a novel tool for the specific activation of genomic androgen signaling and demonstrate the importance of selective pathway activation in androgen-mediated proliferation.


Subject(s)
Prostatic Neoplasms , Receptors, Androgen , Androgens , Animals , G(M1) Ganglioside , Genomics , Humans , Male , Mice , Micelles , Receptors, Androgen/genetics , Signal Transduction , Testosterone
2.
Chemosphere ; 258: 127304, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32559490

ABSTRACT

Humans are exposed to numerous endocrine disruptors on a daily basis, which may interfere with endogenous estrogens, with Di-(2-ethylhexyl) phthalate (DEHP) being one of the most employed. The anterior pituitary gland is a target of 17ß-estradiol (E2) through the specific estrogen receptors (ERs) α and ß, whose expression levels fluctuate in the gland under different contexts, and the ERα/ß index is responsible for the final E2 effect. The aim of the present study was to evaluate in vivo and in vitro the DEHP effects on ERα and ß expression in the pituitary cell population, and also its impact on lactotroph and somatotroph cell growth. Our results revealed that perinatal exposure to DEHP altered the ERα and ß expression pattern in pituitary glands from prepubertal and adult female rats and increased the percentage of lactotroph cells in adulthood. In the in vitro system, DEHP down-regulated ERα and ß expression, and as a result increased the ERα/ß ratio and decreased the percentages of lactotrophs and somatotrophs expressing ERα and ß. In addition, DEHP increased the S + G2M phases, Ki67 index and cyclin D1 in vitro, leading to a rise in the lactotroph and somatotroph cell populations. These results showed that DEHP modified the pituitary ERα and ß expression in lactotrophs and somatotrophs from female rats and had an impact on the pituitary cell growth. These changes in ER expression may be a mechanism underlying DEHP exposure in the pituitary gland, leading to cell growth deregulation.


Subject(s)
Diethylhexyl Phthalate/toxicity , Phthalic Acids/toxicity , Receptors, Estrogen/metabolism , Animals , Cell Proliferation/drug effects , Diethylhexyl Phthalate/metabolism , Endocrine Disruptors/metabolism , Estradiol/metabolism , Estrogen Receptor alpha/metabolism , Estrogens/pharmacology , Female , Lactotrophs/drug effects , Lactotrophs/metabolism , Pituitary Gland/drug effects , Rats
3.
Front Immunol ; 9: 1980, 2018.
Article in English | MEDLINE | ID: mdl-30233581

ABSTRACT

Neutrophils are major effectors of acute inflammation against infection and tissue damage, with ability to adapt their phenotype according to the microenvironment. Although sex hormones regulate adaptive immune cells, which explains sex differences in immunity and infection, little information is available about the effects of androgens on neutrophils. We therefore aimed to examine neutrophil recruitment and plasticity in androgen-dependent and -independent sites under androgen manipulation. By using a bacterial model of prostate inflammation, we showed that neutrophil recruitment was higher in testosterone-treated rats, with neutrophil accumulation being positively correlated to serum levels of testosterone and associated to stronger inflammatory signs and tissue damage. Testosterone also promoted LPS-induced neutrophil recruitment to the prostate, peritoneum, and liver sinusoids, as revealed by histopathology, flow cytometry, and intravital microscopy. Strikingly, neutrophils in presence of testosterone exhibited an impaired bactericidal ability and a reduced myeloperoxidase activity. This inefficient cellular profile was accompanied by high expression of the anti-inflammatory cytokines IL10 and TGFß1, which is compatible with the "N2-like" neutrophil phenotype previously reported in the tumor microenvironment. These data reveal an intriguing role for testosterone promoting inefficient, anti-inflammatory neutrophils that prolong bacterial inflammation, generating a pathogenic environment for several conditions. However, these immunomodulatory properties might be beneficially exploited in autoimmune and other non-bacterial diseases.


Subject(s)
Androgens/metabolism , Escherichia coli Infections/immunology , Neutrophils/immunology , Prostatitis/immunology , Testosterone/metabolism , Urinary Tract Infections/immunology , Uropathogenic Escherichia coli/physiology , Androgens/administration & dosage , Animals , Cells, Cultured , Disease Models, Animal , Humans , Interleukin-10/metabolism , Male , Mice , Mice, Inbred C57BL , Neutrophil Infiltration , Rats , Rats, Wistar , Testosterone/administration & dosage , Transforming Growth Factor beta/metabolism , Tumor Microenvironment
5.
Endocrinology ; 159(2): 945-956, 2018 02 01.
Article in English | MEDLINE | ID: mdl-29194490

ABSTRACT

Androgen signaling in prostate smooth muscle cells (pSMCs) is critical for the maintenance of prostate homeostasis, the alterations of which are a central aspect in the development of pathological conditions. Testosterone can act through the classic androgen receptor (AR) in the cytoplasm, eliciting genomic signaling, or through different types of receptors located at the plasma membrane for nongenomic signaling. We aimed to find evidence of nongenomic testosterone-signaling mechanisms in pSMCs and their participation in cell proliferation, differentiation, and the modulation of the response to lipopolysaccharide. We demonstrated that pSMCs can respond to testosterone by a rapid activation of ERK1/2 and Akt. Furthermore, a pool of ARs localized at the cell surface of pSMCs is responsible for a nongenomic testosterone-induced increase in cell proliferation. Through membrane receptor stimulation, testosterone favors a muscle phenotype, indicated by an increase in smooth muscle markers. We also showed that the anti-inflammatory effects of testosterone, capable of attenuating lipopolysaccharide-induced proinflammatory actions, are promoted only by receptors located inside the cell. We postulate that testosterone might perform prohomeostatic effects through intracellular-initiated mechanisms by modulating cell proliferation and inflammation, whereas some pathological, hyperproliferative actions would be induced by membrane-initiated nongenomic signaling in pSMCs.


Subject(s)
Muscle, Smooth/drug effects , Myocytes, Smooth Muscle/drug effects , Prostate/drug effects , Receptors, Androgen/metabolism , Testosterone/pharmacology , Animals , Cells, Cultured , Male , Muscle, Smooth/metabolism , Myocytes, Smooth Muscle/metabolism , Prostate/cytology , Prostate/metabolism , Rats, Wistar , Signal Transduction/drug effects , Tissue Distribution
6.
Pathog Dis ; 75(7)2017 09 29.
Article in English | MEDLINE | ID: mdl-28911197

ABSTRACT

Candida albicans is the prevalent etiological agent in acute vulvovaginal infection and the most severe chronic condition known as recurrent vulvovaginal candidiasis (VVC). A critical role of local innate immunity in defense and pathogenesis of vaginal infection by Candida is proposed. The fungal recognition by the innate immune receptor is an essential step for the induction of local responses including cytokines and antimicrobial peptides (AMPs) production for host protection. Using TLR2-deficient mice, we characterized the early innate immune response during VVC. Intravaginal challenge of TLR2-/- mice with C. albicans demonstrated that in response to the initial massive penetration, a strong local inflammatory reaction with recruitment of polymorphonuclear neutrophils was developed. Both interleukin 1ß (IL1ß)-regarded as the hallmark of VVC immunopathogenesis-and IL6 were increased in vaginal lavage. Murine beta defensin 1 (mBD1), a constitutive AMP with fungicidal and chemotactic activity, was significantly upregulated in wild type (WT) animals in response to infection. Interestingly, in the absence of TLR2 recognition, levels of mBD1 RNA more than twice higher than those in WT infected animals were observed. Interestingly, our results demonstrate that TLR2 signaling is important to control the fungal burden in the vaginal tract. These finding provide new evidence about the role of this innate receptor during VVC.


Subject(s)
Candidiasis, Vulvovaginal/genetics , Toll-Like Receptor 2/metabolism , Animals , Candida albicans , Candidiasis, Vulvovaginal/microbiology , Cytokines/genetics , Cytokines/metabolism , Female , Genetic Predisposition to Disease , Inflammation , Mice , Mice, Inbred C57BL , Mice, Knockout , Toll-Like Receptor 2/genetics
7.
J Cell Physiol ; 232(10): 2806-2817, 2017 Oct.
Article in English | MEDLINE | ID: mdl-27861881

ABSTRACT

Prostatic smooth muscle cells (pSMCs) differentiation is a key factor for prostatic homeostasis, with androgens exerting multiple effects on these cells. Here, we demonstrated that the myodifferentiator complex Srf/Myocd is up-regulated by testosterone in a dose-dependent manner in primary cultures of rat pSMCs, which was associated to the increase in Acta2, Cnn1, and Lmod1 expressions. Blocking Srf or Myocd by siRNAs inhibited the myodifferentiator effect of testosterone. While LPS led to a dedifferentiated phenotype in pSMCs, characterized by down-regulation of Srf/Myocd and smooth muscle cell (SMC)-restricted genes, endotoxin treatment on Myocd-overexpressing cells did not result in phenotypic alterations. Testosterone at a physiological dose was able to restore the muscular phenotype by normalizing Srf/Myocd expression in inflammation-induced dedifferentiated pSMCs. Moreover, the androgen reestablished the proliferation rate and IL-6 secretion increased by LPS. These results provide novel evidence regarding the myodifferentiating role of testosterone on SMCs by modulating Srf/Myocd. Thus, androgens preserve prostatic SMC phenotype, which is essential to maintain the normal structure and function of the prostate. J. Cell. Physiol. 232: 2806-2817, 2017. © 2016 Wiley Periodicals, Inc.


Subject(s)
Cell Dedifferentiation/drug effects , Myocytes, Smooth Muscle/drug effects , Nuclear Proteins/metabolism , Testosterone/pharmacology , Trans-Activators/metabolism , Transcription Factors/metabolism , Actins/metabolism , Animals , Calcium-Binding Proteins/metabolism , Cell Proliferation/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Interleukin-6/metabolism , Lipopolysaccharides/pharmacology , Male , Microfilament Proteins/metabolism , Myocytes, Smooth Muscle/metabolism , Nuclear Proteins/genetics , Phenotype , Prostate , RNA Interference , Rats, Wistar , Signal Transduction/drug effects , Trans-Activators/genetics , Transcription Factors/genetics , Transfection , Calponins
8.
Cell Immunol ; 280(1): 50-60, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23261829

ABSTRACT

The B subunit of Escherichia coli heat-labile enterotoxin (LTB) acts as efficient mucosal carrier for conjugated antigens. We expressed two heterologous proteins using E. coli as a host: a hybrid consisting of LTB and the A, B and C domain of synapsin (LTBABC) and the separated ABC peptide of this synaptic protein. Refolded LTBABC and LTB bound to the GM1 receptor and internalized into CHO-K1(GM1+) cells. LTBABC showed enhanced solubility and cell binding ability respect to the former hybrid LTBSC. Several oral doses of LTBABC were administered to rats with experimental autoimmune encephalomyelitis (EAE) from induction to the acute stage of the disease. This treatment decreased disease severity, delayed type hypersensitivity reaction and lymph node cell proliferation stimulated by myelin basic protein. Amelioration of EAE was also associated with modulation of the Th1/Th2 cytokine ratio, increased TGF-ß secretion in mesenteric lymph nodes as well as expansion of CD4(+)CD25(+)Foxp3(+) regulatory T cell population. These results indicate that the fusion protein LTBABC is suitable for further exploration of its therapeutic effect on EAE development.


Subject(s)
Bacterial Toxins/therapeutic use , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Enterotoxins/therapeutic use , Escherichia coli Proteins/therapeutic use , Synapsins/therapeutic use , Animals , Bacterial Toxins/chemistry , Bacterial Toxins/genetics , CHO Cells/drug effects , CHO Cells/metabolism , Cattle , Cricetinae , Drug Evaluation, Preclinical , Endocytosis , Enterotoxins/chemistry , Enterotoxins/genetics , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/genetics , Female , G(M1) Ganglioside/metabolism , Lymphocyte Activation/drug effects , Lymphokines/metabolism , Male , Myelin Basic Protein/immunology , Myelin Basic Protein/toxicity , Peptide Fragments/chemistry , Peptide Fragments/therapeutic use , Protein Denaturation , Protein Folding , Protein Structure, Tertiary , Random Allocation , Rats , Rats, Wistar , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/therapeutic use , Single-Blind Method , Structure-Activity Relationship , Synapsins/chemistry , Synapsins/genetics , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology
SELECTION OF CITATIONS
SEARCH DETAIL